Actively Recruiting
Antenatal Stress and Infants In MAR
Led by IRCCS Eugenio Medea · Updated on 2026-02-13
100
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
Sponsors
I
IRCCS Eugenio Medea
Lead Sponsor
A
A.O. Ospedale Papa Giovanni XXIII
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational longitudinal study is to examine the association between prenatal psychological and biological stress and neonatal health outcomes in couples who conceived through medically assisted reproduction. The study includes expectant mothers and fathers during pregnancy and at birth and focuses on pregnancies achieved through homologous fertilization and heterologous fertilization via oocyte donation. The main questions this study aims to answer are: 1. How do psychological and biological indicators of stress manifest during pregnancy in women who have undergone medically assisted reproduction? 2. Is prenatal maternal stress associated with neonatal health outcomes independently of genetic factors? 3. How does perceived stress present in expectant fathers during pregnancy? Researchers will compare couples who conceived through homologous fertilization with couples who conceived through heterologous fertilization via oocyte donation to understand whether associations between prenatal maternal stress and neonatal outcomes are independent of shared genetic background. Participants will: * Complete a remote eligibility assessment collecting information on pregnancy characteristics, parental health, and maternal psychological well-being * Complete online questionnaires at multiple time points during pregnancy and at birth assessing anxiety and depressive symptoms, perceived social support, and self-efficacy (both parents), as well as pregnancy-specific measures and prenatal bonding (mothers only) * In late pregnancy, mothers will collect saliva samples at home over two consecutive days to assess biological markers of stress (cortisol and alpha-amylase)
CONDITIONS
Official Title
Antenatal Stress and Infants In MAR
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women in the first trimester and their respective partners
- Pregnancy achieved through homologous assisted reproduction techniques
- Pregnancy achieved through heterologous assisted reproduction via oocyte donation
- Singleton pregnancy
- Pregnancy achieved through FIVET techniques
You will not qualify if you...
- Parents under 18 years of age
- Pregnancy achieved through heterologous assisted reproduction via donor sperm
- Pregnancy achieved without FIVET techniques
- Maternal hypertension during pregnancy
- Endocrine or immune system disorders during pregnancy
- Chronic use of medications during pregnancy (including anti-inflammatory drugs, antidepressants, or steroids)
- Alcohol or substance abuse
- Smoking during pregnancy
- Psychiatric disorders other than anxiety or depression
- Pregnancy or perinatal complications
- Multiple pregnancy (twins or higher-order multiples)
- Preterm birth (before 35 weeks of gestation)
- Health problems in the newborn at birth
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ospedale Papa Giovanni XXIII
Bergamo, Bergamo, Italy, 24127
Actively Recruiting
Research Team
A
Alessandra Frigerio, PhD
CONTACT
S
Simone Forni
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here